Post-IPO Equity - Eiger BioPharmaceuticals - Apr 29, 2016 Funding Round Profile - Cointime

Bitcoin $78,840.04 +2.93%
Ethereum $3,172.66 +4.05%
BNB $629.03 -0.49%
Optimism $1.66 +0.11%
Arbitrum $0.62 +1.63%
Solana $205.26 +1.79%
Polygon $0.40 +3.15%
Cosmos $4.94 +3.56%
Avalanche $31.50 +6.93%

Bitcoin $78,840.04 +2.93%
Ethereum $3,172.66 +4.05%
BNB $629.03 -0.49%
Optimism $1.66 +0.11%
Arbitrum $0.62 +1.63%
Solana $205.26 +1.79%
Polygon $0.40 +3.15%
Cosmos $4.94 +3.56%
Avalanche $31.50 +6.93%

Eiger BioPharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 2.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Nov 23, 2015	Debt Financing	$ 6M		Detail
Apr 15, 2011	Series A	$ 14.46M	InterWest Partners,Vivo Capital	Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail
Mar 21, 2016	Debt Financing	0	InterWest Partners	Detail
Mar 23, 2016	IPO	0		Detail